Erythroped ® is the most recent development of erythromycin producing a highly stable ester. This new presentation was first available in 1963 and was stable enough to allow the formulation of suspensions. Erythroped is available as 500mg tablets and 125mg/250mg/500mg/5ml suspensions.
